Gastrointestinal Therapeutics Market Report 2026
Download Free Sample Buy Now
Gastrointestinal Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gastrointestinal Therapeutics Market Report 2026

Global Outlook – By Product (Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics), By Route Of Administration (Oral, Intravenous, Other Routes Of Administration), By Application (Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Gastrointestinal Therapeutics Market Overview

• Gastrointestinal Therapeutics market size has reached to $42.3 billion in 2025

• Expected to grow to $55.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%

• Growth Driver: The Rise In Inflammatory Bowel Diseases Drives The Growth Of The Market Due To Increasing Demand For Targeted Therapeutics

• Market Trend: Innovative Capsule Therapy Enhances Treatment Outcomes And Patient Compliance

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Therapeutics Market?

Gastrointestinal therapeutics refers to the range of drugs, biologics, and treatment solutions used to prevent, manage, or cure disorders affecting the gastrointestinal tract, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. These therapies target conditions such as acid reflux, ulcers, irritable bowel syndrome, Crohn’s disease, and gastrointestinal cancers.

The main product types of gastrointestinal therapeutics are over-the-counter gastrointestinal therapeutics and prescription-based gastrointestinal therapeutics. Over-the-counter gastrointestinal therapeutics refers to non-prescription medications used to relieve common digestive issues such as heartburn, indigestion, gas, constipation, and diarrhea. These therapeutics are administered through various routes of administration, including oral, intravenous, and others. They are used for several applications, such as inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcer disease, irritable bowel syndrome, and others. The products are distributed through multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized by a range of end users such as hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, and others.

Gastrointestinal Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Gastrointestinal Therapeutics Market Size and Share 2026?

The gastrointestinal therapeutics market size has grown strongly in recent years. It will grow from $42.3 billion in 2025 to $44.72 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of biologics and advanced gastrointestinal therapies, increasing incidence of acid reflux and ulcers, reliance on hospital and clinic-based treatment, growing awareness of digestive health, dominance of traditional otc antacids and laxatives.

What Is The Gastrointestinal Therapeutics Market Growth Forecast?

The gastrointestinal therapeutics market size is expected to see strong growth in the next few years. It will grow to $55.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to development of targeted biologics and immunotherapies, expansion of ambulatory surgical centers and diagnostic laboratories, rising adoption of oral and intravenous delivery systems, increasing online pharmacy penetration, innovation in probiotics and digestive enzyme formulations. Major trends in the forecast period include rising prevalence of gastrointestinal disorders, increased adoption of biologics and advanced therapies, expansion of over-the-counter therapeutics, growing focus on personalized gastrointestinal treatments, rising online and retail pharmacy distribution.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastrointestinal Therapeutics Market Segmentation

1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics

2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products

2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

What Is The Driver Of The Gastrointestinal Therapeutics Market?

The rising inflammatory bowel diseases is expected to propel the growth of the gastrointestinal therapeutics market going forward. Inflammatory bowel disease (IBD) is a chronic condition that causes inflammation of the digestive tract, primarily including Crohn's disease and ulcerative colitis. The rising inflammatory bowel diseases are due to genetic susceptibility, causing an abnormal immune response to gut microbes. Gastrointestinal therapeutics help manage and treat bowel diseases by targeting underlying inflammation, regulating digestive functions, and alleviating associated symptoms to improve patient outcomes. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, over 5,300 individuals with inflammatory bowel diseases (IBD) were registered in 2023, marking an increase of more than 3,000 members from 2022. Therefore, the rising inflammatory bowel diseases is driving the growth of the gastrointestinal therapeutics industry.

Key Players In The Global Gastrointestinal Therapeutics Market

Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

Global Gastrointestinal Therapeutics Market Trends and Insights

Major companies operating in the gastrointestinal therapeutics market are focusing on developing innovative therapies, such as sustained-release (SR) fixed-dose combination capsules, to improve patient compliance and enhance treatment effectiveness. Sustained-release (SR) fixed-dose combination capsules are oral medications that gradually release multiple active ingredients over time to maintain consistent drug levels and reduce dosing frequency. For instance, in June 2024, Akums Drugs and Pharmaceuticals Limited, an India-based pharmaceutical preparation manufacturing company, launched rabeprazole + levosulpiride SR capsules for treating gastrointestinal disorders in India. This formulation combines rabeprazole, a proton pump inhibitor that decreases stomach acid, with levosulpiride, a prokinetic agent that improves gut motility. Together, they offer effective relief from symptoms such as heartburn, acid reflux, bloating, and indigestion. This combination is widely prescribed for managing gastroesophageal reflux disease, peptic ulcers, and other related gastrointestinal (GI) conditions.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastrointestinal Therapeutics Market?

In April 2023, Merck and Co., Inc., a US-based pharmaceutical company, acquired Prometheus Biosciences, Inc., for $10.8 billion. With this acquisition, Merck and Co., Inc., aims to strengthen its immunology pipeline by advancing precision-based therapies for inflammatory diseases such as ulcerative colitis and Crohn’s disease. Prometheus Biosciences, Inc. is a US-based biotechnology company that specializes in precision therapeutics for immune-mediated diseases, particularly gastrointestinal disorders.

Regional Insights

North America was the largest region in the gastrointestinal therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Therapeutics Market?

The gastrointestinal therapeutics market consists of sales of acid suppressants, antiemetic agents, antispasmodics, digestive enzymes, and prebiotics and probiotics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Therapeutics Market Report 2026?

The gastrointestinal therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gastrointestinal Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $44.72 billion
Revenue Forecast In 2035 $55.21 billion
Growth Rate CAGR of 5.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Route Of Administration, Application, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastrointestinal Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastrointestinal Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Prevalence Of Gastrointestinal Disorders

4.2.2 Increased Adoption Of Biologics And Advanced Therapies

4.2.3 Expansion Of Over-The-Counter Therapeutics

4.2.4 Growing Focus On Personalized Gastrointestinal Treatments

4.2.5 Rising Online And Retail Pharmacy Distribution

5. Gastrointestinal Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Ambulatory Surgical Centers

5.4 Diagnostic Laboratories

5.5 Pharmacies

6. Gastrointestinal Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastrointestinal Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastrointestinal Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastrointestinal Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastrointestinal Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Therapeutics Market Segmentation

9.1. Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics

9.2. Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Other Routes Of Administration

9.3. Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications

9.4. Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users

9.6. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products

9.7. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics

10. Gastrointestinal Therapeutics Market Regional And Country Analysis

10.1. Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Therapeutics Market

11.1. Asia-Pacific Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Therapeutics Market

12.1. China Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Therapeutics Market

13.1. India Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Therapeutics Market

14.1. Japan Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Therapeutics Market

15.1. Australia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Therapeutics Market

16.1. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Therapeutics Market

17.1. South Korea Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Therapeutics Market

18.1. Taiwan Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Therapeutics Market

19.1. South East Asia Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Therapeutics Market

20.1. Western Europe Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Therapeutics Market

21.1. UK Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Therapeutics Market

22.1. Germany Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Therapeutics Market

23.1. France Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Therapeutics Market

24.1. Italy Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Therapeutics Market

25.1. Spain Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Therapeutics Market

26.1. Eastern Europe Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Therapeutics Market

27.1. Russia Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Therapeutics Market

28.1. North America Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Therapeutics Market

29.1. USA Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Therapeutics Market

30.1. Canada Gastrointestinal Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Therapeutics Market

31.1. South America Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Therapeutics Market

32.1. Brazil Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Therapeutics Market

33.1. Middle East Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Therapeutics Market

34.1. Africa Gastrointestinal Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastrointestinal Therapeutics Market, Segmentation By Product, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Therapeutics Market Regulatory and Investment Landscape

36. Gastrointestinal Therapeutics Market Competitive Landscape And Company Profiles

36.1. Gastrointestinal Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastrointestinal Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastrointestinal Therapeutics Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Otsuka Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Therapeutics Market Other Major And Innovative Companies

Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation

38. Global Gastrointestinal Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Therapeutics Market

40. Gastrointestinal Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Gastrointestinal Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastrointestinal Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastrointestinal Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastrointestinal Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastrointestinal Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastrointestinal Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Gastrointestinal Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Gastrointestinal Therapeutics Market, Major Resource Providers
  • Table 6: Global Gastrointestinal Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastrointestinal Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Gastrointestinal Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Gastrointestinal Therapeutics Market, Major Trends
  • Table 10: Global Gastrointestinal Therapeutics Market, Major End Users
  • Table 11: Global Gastrointestinal Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastrointestinal Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastrointestinal Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastrointestinal Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Gastrointestinal Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Gastrointestinal Therapeutics Market - Company Scoring Matrix
  • Table 98: Abbott Laboratories Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Takeda Pharmaceutical Company Limited. Financial Performance
  • Table 101: Boehringer Ingelheim International GmbH Financial Performance
  • Table 102: Otsuka Holdings Co. Ltd. Financial Performance
  • Table 103: Global Gastrointestinal Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Gastrointestinal Therapeutics Market, Competitive Dashboard
  • Table 105: Global Gastrointestinal Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 107: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 108: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Gastrointestinal Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastrointestinal Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastrointestinal Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Gastrointestinal Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Gastrointestinal Therapeutics Market, Major Resource Providers
  • Figure 6: Global Gastrointestinal Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastrointestinal Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastrointestinal Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Gastrointestinal Therapeutics Market, Major Trends
  • Figure 10: Global Gastrointestinal Therapeutics Market, Major End Users
  • Figure 11: Global Gastrointestinal Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastrointestinal Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastrointestinal Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastrointestinal Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Gastrointestinal Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Gastrointestinal Therapeutics Market - Company Scoring Matrix
  • Figure 98: Abbott Laboratories Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Takeda Pharmaceutical Company Limited. Financial Performance
  • Figure 101: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 102: Otsuka Holdings Co. Ltd. Financial Performance
  • Figure 103: Global Gastrointestinal Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Gastrointestinal Therapeutics Market, Competitive Dashboard
  • Figure 105: Global Gastrointestinal Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 107: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 108: Global, Gastrointestinal Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

Gastroparesis Drugs Market Report 2026 - Global Outlook – By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), ...

Digestive and Intestinal Remedies Market Report 2026 - Global Outlook – By Type (Digestive Medicines, Remedies Against Gastrointestinal Complaints, Natural And Synthetic Agents), By Age Group (Pediatric, Adults), By Dist...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) – Market...

Gastroesophageal Reflux Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), ...

Intestine Cancer Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Immunotherapy, Chemotherapy, Other Treatments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By App...

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Gastrointestinal Devices Market Report 2026 - Global Outlook – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, End...

Frequently Asked Questions

The Gastrointestinal Therapeutics market was valued at $42.3 billion in 2025, increased to $44.72 billion in 2026, and is projected to reach $55.21 billion by 2030.

The global Gastrointestinal Therapeutics market is expected to grow at a CAGR of 5.4% from 2026 to 2035 to reach $55.21 billion by 2035.

Some Key Players in the Gastrointestinal Therapeutics market Include, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy’s Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation .

Major trend in this market includes: Innovative Capsule Therapy Enhances Treatment Outcomes And Patient Compliance. For further insights on this market. request a sample here

North America was the largest region in the gastrointestinal therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us